Patent Term Extension Application for ProVee® System for BPH, Patent No. 10,881,539 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2026-E-8234

Patent Term Extension Application for ProVee® System for BPH, Patent No. 10,881,539

Documents

Comments

Description

OPEN

Comment Period OpensJul 30, 2026

Type	Title	Posted	Comments	Status
Other	Letter from U. S. Patent and Trademark Office to FDA CDER	Jul 30, 2026	--

CDER

Patent Term Extension Application for

ProVee® System for BPH

Patent No. 10,881,539

Knobbe, Martens, Olson & Bear LLP

ProVerum Limited

OPEN